Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study-Reference-Cited by-同舟云学术

Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study

Published:2019-11-08 Issue:6 Volume:197 Page:741-751
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Zeng Wan-Qin,Feng Wen,Xie Li,Zhang Chen-Chen,Yu Wen,Cai Xu-Wei,Fu Xiao-Long^ORCID

Funder

National Key Research and Development Program of China

The Project of Multi-center Clinical Research, Shanghai Jiao Tong University School of Medicine

Shanghai Chest Hospital Project of Collaborative Innovation

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00408-019-00284-7.pdf

Reference39 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

2. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34

3. Le Pechoux C (2011) Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 16:672–681

4. Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136:260–271

5. National Comprehensive Cancer Network. NCCN Guidelines in Non-small-cell lung cancer (Version 3. 2019). https://www.nccn.org . Accessed 21 March 2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of postoperative radiotherapy in resected pⅢA-N2 EGFR mutant and wild-type lung adenocarcinoma;iScience;2024-07

2. Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?;Current Opinion in Oncology;2023-10-20

3. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer;World Journal of Surgical Oncology;2023-08-04

4. Trimodal Therapy and Surgical Approaches in Stage Iiia/N2 Non-Small Cell Lung Cancer;2023

5. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA‐N2 resected non‐small cell lung cancer;Thoracic Cancer;2022-08-23